These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6895241)

  • 21. [New concepts in the therapy of mucostasis].
    von Seefeld H; Weiss JM; Rensch H
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():896-900. PubMed ID: 6689074
    [No Abstract]   [Full Text] [Related]  

  • 22. [Animal experiments on the effect of various drugs on the lecithin content and fibrinolytic activity of the fetal lung].
    Krieglsteiner P; Lohninger A; Haas S; Wriedt-Lübbe I; Blümel G
    Arch Gynecol; 1979 Jul; 228(1-4):204-5. PubMed ID: 582653
    [No Abstract]   [Full Text] [Related]  

  • 23. Surfactant in the amniotic fluid and bromhexine metabolite VIII.
    Merkus JM; Roozen PH; Verhoeven AG; Kock HC
    Eur J Obstet Gynecol Reprod Biol; 1978 Apr; 8(2):99-102. PubMed ID: 400861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacologic influencing of fetal phospholipide synthesis. Part I: Effect of betamethasone and bromohexine metabolit VIII (Ambroxol) (author's transl)].
    Krieglsteiner P; Lohninger A; Münnich W; Neiss A; Blümel G
    Z Geburtshilfe Perinatol; 1978 Feb; 182(1):16-28. PubMed ID: 645162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of Ambroxol on bleomycin-induced changes in phospholipid composition of rat lung surfactant.
    Stettner S; Ledwozyw A
    Acta Physiol Hung; 1995; 83(2):181-7. PubMed ID: 8588505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clearance of 99mTc-DTPA and experimentally increased alveolar surfactant content.
    Bos JA; Wollmer P; Bakker W; Hannappel E; Lachmann B
    J Appl Physiol (1985); 1992 Apr; 72(4):1413-7. PubMed ID: 1592733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of ambroxol on the bronchopulmonary level of antibiotics.
    Wiemeyer JC
    Arzneimittelforschung; 1981; 31(6):974-6. PubMed ID: 7196243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic study on ambroxol in chronic bronchopulmonary diseases (author's transl)].
    Curti PC; Renovanz HD
    Arzneimittelforschung; 1978; 28(5a):922-5. PubMed ID: 581991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A comparative morphological and chemical study of the ambroxol and chlorphentermine action on the lung phospholipid content (author's transl)].
    Meerbach W; Gräbner R; Dietz W; Böttger W
    Zentralbl Allg Pathol; 1982; 126(1-2):185-95. PubMed ID: 7090596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of ambroxol on lung tissue penetration of amoxicillin.
    Spátola J; Poderoso JJ; Wiemeyer JC; Fernández M; Guerreiro RB; Corazza C
    Arzneimittelforschung; 1987 Aug; 37(8):965-6. PubMed ID: 3675694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibition of lysosomal phospholipase A from rabbit lung by ambroxol and its consequences for pulmonary surfactant.
    Heath MF; Jacobson W
    Lung; 1985; 163(6):337-44. PubMed ID: 3937951
    [No Abstract]   [Full Text] [Related]  

  • 32. [Appearance of lamellar bodies in pulmonary cells from 8-12-week-old human fetuses under the effect of ambroxol in vitro].
    Zsolnai B; Gyévai A
    Morphol Igazsagugyi Orv Sz; 1984 Jul; 24(3):189-94. PubMed ID: 6482889
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of ambroxol on mucociliary clearance (author's transl)].
    Weiss T; Dorow P; Felix R
    Prax Klin Pneumol; 1981 Aug; 35(8):359-62. PubMed ID: 7345432
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of ambroxol on human phagocytic cell function.
    Capsoni F; Ongari AM; Minonzio F; Lazzarin A; Zavattini G
    Boll Ist Sieroter Milan; 1985; 64(3):236-9. PubMed ID: 3899138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effectiveness of lasolvan and bromhexine in chronic nonspecific lung diseases].
    Solopov VN; Lunichkina IV; Plisko LF
    Sov Med; 1989; (6):82-4. PubMed ID: 2678522
    [No Abstract]   [Full Text] [Related]  

  • 36. [Identification of tissue inhibitors of plasmin and the effect of betamethasone and ambroxol].
    Blasini R; Haas-Denk S; Krieglsteiner P; Wriedt-Lübbe I; Erhardt W
    Med Welt; 1977 Sep; 28(35):1392-4. PubMed ID: 142894
    [No Abstract]   [Full Text] [Related]  

  • 37. [Secretodynamic activity of ambroxol in the experimental animal: comparison with bromhexine, sobrerol, domiodol and N-acetyl-L-cysteine].
    Cadel S; Maiorino M; Riunno M; Schiantarelli P
    Boll Chim Farm; 1982 Sep; 121(9):475-82. PubMed ID: 7159512
    [No Abstract]   [Full Text] [Related]  

  • 38. Lung compliance and alveolar expansion in the artificially ventilated premature newborn rabbit after maternal treatment with ambroxol.
    Lachmann B; Tischer AB; Grossmann G; Robertson B
    Respiration; 1981; 42(3):209-16. PubMed ID: 7313347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical experience with ambroxol syrup (author's transl)].
    Göbel P; Rensch H
    Arzneimittelforschung; 1978; 28(5a):929-31. PubMed ID: 581992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Additive action of theophylline and ambroxol on bronchial clearance?].
    Würtemberger G; Michaelis K; Matthys H
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():300-3. PubMed ID: 3174582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.